Extracorporeal life support devices and strategies for management of acute cardiorespiratory failure in adult patients: a comprehensive review
Open Access
- 1 January 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 18 (2), 219
- https://doi.org/10.1186/cc13865
Abstract
Evolution of extracorporeal life support (ECLS) technology has added a new dimension to the intensive care management of acute cardiac and/or respiratory failure in adult patients who fail conventional treatment. ECLS also complements cardiac surgical and cardiology procedures, implantation of long-term mechanical cardiac assist devices, heart and lung transplantation and cardiopulmonary resuscitation. Available ECLS therapies provide a range of options to the multidisciplinary teams who are involved in the time-critical care of these complex patients. While venovenous extracorporeal membrane oxygenation (ECMO) can provide complete respiratory support, extracorporeal carbon dioxide removal facilitates protective lung ventilation and provides only partial respiratory support. Mechanical circulatory support with venoarterial (VA) ECMO employed in a traditional central/peripheral fashion or in a temporary ventricular assist device configuration may stabilise patients with decompensated cardiac failure who have evidence of end-organ dysfunction, allowing time for recovery, decision-making, and bridging to implantation of a long-term mechanical circulatory support device and occasionally heart transplantation. In highly selected patients with combined severe cardiac and respiratory failure, advanced ECLS can be provided with central VA ECMO, peripheral VA ECMO with timely transition to venovenous ECMO or VA-venous ECMO upon myocardial recovery to avoid upper body hypoxia or by addition of an oxygenator to the temporary ventricular assist device circuit. This article summarises the available ECLS options and provides insights into the principles and practice of these techniques. One should emphasise that, as is common with many emerging therapies, their optimal use is currently not backed by quality evidence. This deficiency needs to be addressed to ensure that the full potential of ECLS can be achieved.Keywords
This publication has 60 references indexed in Scilit:
- Extracorporeal Membrane Oxygenation CircuitryPediatric Critical Care Medicine, 2013
- Lower tidal volume strategy (≈3 ml/kg) combined with extracorporeal CO2 removal versus ‘conventional’ protective ventilation (6 ml/kg) in severe ARDSIntensive Care Medicine, 2013
- Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenationJournal of Critical Care, 2012
- Extracorporeal membrane oxygenation for respiratory failure in adultsCurrent Opinion in Critical Care, 2012
- A Review of the Fundamental Principles and Evidence Base in the Use of Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Adult PatientsJournal of Intensive Care Medicine, 2011
- Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarctionCritical Care, 2010
- Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress SyndromePublished by American Medical Association (AMA) ,2009
- Critically Ill Patients With 2009 Influenza A(H1N1) Infection in CanadaPublished by American Medical Association (AMA) ,2009
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009
- Wang-Zwische Double Lumen Cannula—Toward a Percutaneous and Ambulatory Paracorporeal Artificial LungASAIO Journal, 2008